North Star Investment Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Sell
656
-24
-4% -$4.51K 0.01% 574
2026
Q1
$134K Buy
680
+11
+2% +$2.12K 0.01% 555
2025
Q4
$123K Buy
669
+42
+7% +$7.37K 0.01% 515
2025
Q3
$96.2K Buy
627
+4
+0.6% +$605 0.01% 536
2025
Q2
$87.1K Hold
623
0.01% 543
2025
Q1
$91.6K Hold
623
0.01% 520
2024
Q4
$81.7K Hold
623
0.01% 548
2024
Q3
$97.1K Hold
623
0.01% 503
2024
Q2
$97.2K Sell
623
-10
-2% -$1.5K 0.01% 503
2024
Q1
$85.7K Buy
633
+113
+22% +$15K 0.01% 533
2023
Q4
$70K Hold
520
0.01% 543
2023
Q3
$70.4K Hold
520
0.01% 541
2023
Q2
$74.4K Hold
520
0.01% 546
2023
Q1
$72.1K Buy
520
+500
+2,500% +$67.3K 0.01% 563
2022
Q4
$2.64K Buy
20
+10
+100% +$1.25K ﹤0.01% 1046
2022
Q3
$1K Hold
10
﹤0.01% 1057
2022
Q2
$1K Hold
10
﹤0.01% 1063
2022
Q1
$1K Sell
10
-535
-98% -$64.2K ﹤0.01% 1079
2021
Q4
$63K Buy
545
+535
+5,350% +$63K ﹤0.01% 566
2021
Q3
$1K Hold
10
﹤0.01% 1060
2021
Q2
$1K Hold
10
﹤0.01% 1041
2021
Q1
$1K Hold
10
﹤0.01% 1003
2020
Q4
$1K Hold
10
﹤0.01% 979
2020
Q3
$1K Buy
+10
New +$1.11K ﹤0.01% 963
2014
Q2
Sell
-56
Closed -$4K 677
2014
Q1
$4K Buy
+56
New +$3.62K ﹤0.01% 605

Other funds holding AZN

North Star Investment Management's AZN Position: Q2 2026 in Review

North Star Investment Management reduced its AstraZeneca (AZN) stake by 3.5% in Q2 2026, selling an estimated $4.51K and leaving 656 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #574.

North Star Investment Management first reported a position in AZN in Q1 2014 and has held it in 25 quarters since. The position peaked at $134K in Q1 2026. 578 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • North Star Investment Management held 656 shares of AstraZeneca worth $124K as of Q2 2026.
  • North Star Investment Management sold 24 AstraZeneca shares in Q2 2026, an estimated $4.51K.
  • AstraZeneca made up 0.01% of North Star Investment Management's portfolio in Q2 2026, its #574 holding.
  • North Star Investment Management first reported a position in AstraZeneca in Q1 2014 and has held it in 25 quarters since.
  • North Star Investment Management's AstraZeneca position peaked at $134K in Q1 2026.
  • 578 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.